EASTERN COOPERATIVE ONCOLOGY GROUP

东方肿瘤合作组

• 批准号: 3556293
• 负责人: Janice Phillips Dutcher
• 金额: $ 12.64万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-06-01 至 1994-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3556293
• 关键词: 13 cis retinoate; Hodgkin's disease; acute leukemia; acute lymphocytic leukemia; antineoplastics; azacitidine; bone marrow transplantation; breast neoplasms; cervix neoplasms; cis platinum compound; clinical trials; colon neoplasms; colony stimulating factor; combination cancer therapy; combination chemotherapy; cooperative study; cytogenetics; cytosine arabinoside; dosage; drug adverse effect; drug metabolism; esophagus neoplasm; estrogen receptors; etoposide; flow cytometry; fluorouracil; harringtonines; head /neck neoplasm; homologous transplantation; hormone therapy; human subject; human therapy evaluation; hybridomas; immunoglobulin genes; interferons; interleukin 2; kidney neoplasms; lung neoplasms; lymphoma; melanoma; methotrexate; mitoxantrone; monoclonal antibody; myelogenous leukemia; neoplasm /cancer chemotherapy; neoplasm /cancer classification /staging; neoplasm /cancer diagnosis; neoplasm /cancer immunodiagnosis; neoplasm /cancer radiation therapy; neoplasm /cancer remission /regression; ovary neoplasms; paclitaxel; vinblastine

The Albert Einstein College of Medicine and its affiliates propose to continue to participate in the scientific, educational, and cancer control activities of the Eastern Cooperative Oncology Group (ECOG). This institution, in addition to its unique capability to conduct cancer treatment clinical trials involving laboratory and clinical collaboration, has access to the large numbers of patients required for phase III and combined-modality trials. Investigators from the disciplines of medical oncology, radiation oncology, surgery and gynecologic oncology have and propose to continue to participate in the design, implementation and analysis of ECOG studies at Einstein. In addition, pathologists and immunologists who have collaborated with clinical investigators in the conduct of ECOG trials at this institution propose to continue that collaboration. The institution proposes to continue to provide a group-wide immunoreference laboratory for the Hematology Committee of ECOG. This institution and one of its affiliates (New York Medical College) proposes to continue active participation in the ECOG Bone Marrow Transplant Committee. The State of New York has approved a Certificate of Need for Allogeneic Bone Marrow Transplantation for both Einstein and New York Medical College. It will, therefore, be possible for both institutions to participate in studies of this modality within ECOG. Einstein proposes to increase its accrual to ECOG studies by extending its CGOP network to include additional productive institutions with extensive clinical trials experience and capability.

阿尔伯特·爱因斯坦医学院及其附属机构提出 继续参与科学、教育和 东方合作肿瘤学小组的癌症控制活动 (ECOG)。这个机构，除了它独特的能力之外， 进行癌症治疗的临床试验，包括实验室和 临床协作，可以接触到大量的患者 第三阶段和联合模式试验所需的。调查人员 从医学肿瘤学，放射肿瘤学， 外科和妇科肿瘤学已经并提议继续 参与ECOG的设计、实施和分析 在爱因斯坦学习。此外，病理学家和免疫学家 他们与临床调查人员合作进行了 在该机构进行的ECOG试验建议继续这样做 协作。该机构建议继续提供一项 血液学委员会全组免疫参考实验室 是ECOG的。 该机构及其附属机构之一(纽约医疗 学院)建议继续积极参加经社理事会 骨髓移植委员会。纽约州已经 批准需要异基因骨髓的证书 爱因斯坦和纽约医学院的移植手术。 因此，这两个机构都有可能 参加经社理事会关于这一模式的研究。 爱因斯坦建议通过以下方式增加对ECOG研究的应计收入 扩展其CGOP网络，以包括其他生产力 具有丰富的临床试验经验和 能力。